Evidence Hub

Exceptional and typical biomarker responses to AminoTriComplex in metastatic prostate cancer: a case series

Tavartkiladze A, Simonia G, Reiter RJ, Lou R, Okrostsvaridze N, Kasradze D, Revazishvili P, Andronikashvili I et al.

Journal of medical case reports, 2026

Abstract

Background: Metastatic prostate cancer (mPCa) remains a major cause of mortality in men. AminoTriComplex, a multicomponent phytochemical-melatonin formulation, targets inflammation, extracellular matrix remodeling, androgen receptor signaling, and circadian dysregulation.

Case presentation: We present a case series of eight Caucasian/White male patients (aged 58-73 years; median 66) with histologically confirmed metastatic castration-resistant prostate cancer (mCRPC) from the active treatment arm of a double-blind, placebo-controlled trial. Patients received AminoTriComplex as adjuvant therapy alongside standard of care. Seven "typical" responders were associated with deep prostate-specific antigen (PSA) declines (79-89%), matrix metalloproteinase-9 (MMP-9) reductions (45-55%), interleukin-6 (IL-6) decreases (55-62%), and universal AR-V7 conversion to negative. One "exceptional" responder (a 62-year-old Caucasian/White man) was associated with a 96% PSA decline, normalization of inflammatory and protease biomarkers, complete AR-V7 clearance, restoration of circadian rhythm, and > 30% radiographic regression per RECIST 1.1 criteria for nodal disease.

Mechanistic substudy: Tumor biopsies and blood demonstrated strengthened MT1 melatonin receptor expression, synchronous downregulation of Survivin, and elevation of Cystatin C, aligning with clinical biomarker shifts.

Conclusions: AminoTriComplex was associated with consistent biomarker modulation and occasional exceptional…

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free